Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 2/20 | 0.54 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | HTT | P42858 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4884887 | 1.00 | KCNK3 (0.54) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL2907123 | 0.92 | MAPT (0.53) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL2907122 | 0.92 | MAPT (0.53) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4878943 | 0.87 | MAPT (0.54) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4890013 | 0.87 | MAPT (0.57) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4882274 | 0.87 | MAPT (0.59) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4890021 | 0.87 | MAPT (0.57) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4882272 | 0.87 | MAPT (0.59) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4878940 | 0.87 | MAPT (0.54) | KCNK3KCNK9MAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL4878056 | 0.87 | MAPT (0.48) | MAPTALDH1A1SMN1; SMN2RAB9ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080227787-A1 | Use of New Lipoxygenase Inhibitors | BIOLIPOX AB (SE) | 2008-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227787-A1 | Use of New Lipoxygenase Inhibitors | ALOX15, ALOX15B, ALOX12 | KCNK3 3612/4885KCNK9 4036/4885MAPT 4603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.